Header Logo

Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by NICOLAUS WAGNER-BARTAK and SELVI THIRUMURTHI.
NICOLAUS WAGNER-BARTAK
Connection Strength
0.162
SELVI THIRUMURTHI
  1. Author Correction: Longitudinal single-cell profiling reveals molecular heterogeneity and tumor-immune evolution in refractory mantle cell lymphoma. Nat Commun. 2024 Oct 07; 15(1):8668.
    View in: PubMed
    Score: 0.062
  2. Ibrutinib-rituximab followed by R-HCVAD as frontline treatment for young patients (=65 years) with mantle cell lymphoma (WINDOW-1): a single-arm, phase 2 trial. Lancet Oncol. 2022 03; 23(3):406-415.
    View in: PubMed
    Score: 0.051
  3. Longitudinal single-cell profiling reveals molecular heterogeneity and tumor-immune evolution in refractory mantle cell lymphoma. Nat Commun. 2021 05 17; 12(1):2877.
    View in: PubMed
    Score: 0.049
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.